词条 | FANCF | |||||||||||||||||||||
释义 |
InteractionsFANCF has been shown to interact with Fanconi anemia, complementation group C,[3][4] FANCG,[3][4][5][6] FANCA[3][4][7] and FANCE.[3][8] FunctionFANCF is an adaptor protein that plays a key role in the proper assembly of the FA core complex.[3] The FA core complex is composed of eight proteins (FANCA, -B, -C, -E, -F, -G, -L and -M).[9][10] FANCF stabilizes the interaction between the FANCC/FANCE subcomplex and the FANCA/FANCG subcomplex and locks the whole FA core complex in a conformation that is essential to perform its function in DNA repair.[3] The FA core complex is a nuclear core complex that is essential for the monoubiquitination of FANCD2 and this modified form of FANCD2 colocalizes with BRCA1, RAD51 and PCNA in foci that also contain other DNA repair proteins.[3] All these proteins function together to facilitate DNA interstrand cross-link repair. They also function in other DNA damage response repair processes including recovering and stabilizing stalled replication forks.[10] FoxF1 protein also interacts with the FA protein core and induces its binding to chromatin to promote DNA repair.[10] CancerDNA damage appears to be the primary underlying cause of cancer,[11][12] and deficiencies in expression of DNA repair genes appear to underlie many forms of cancer.[13][14] If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase mutations due to error-prone translesion synthesis. Excess DNA damage may also increase epigenetic alterations due to errors during DNA repair.[15][16] Such mutations and epigenetic alterations may give rise to cancer. Reductions in expression of DNA repair genes (usually caused by epigenetic alterations) are very common in cancers, and are most often much more frequent than mutational defects in DNA repair genes in cancers.[17] (Also see Frequencies of epimutations in DNA repair genes.) Methylation of the promoter region of the FANCF gene causes reduced expression of FANCF protein.[18] The frequencies of FANCF promoter methylation in several different cancers is indicated in the table.
In invasive breast cancers, microRNA-210 (miR-210) was increased, along with decreased expression of FANCF, where FANCF was one of the likely targets of miR-210.[25] Although mutations in FANCF are ordinarily not observed in human tumors, an FANCF-deficient mouse model was prone to ovarian cancers.[26] FANCF appears to be one of about 26 DNA repair genes that are epigenetically repressed in various cancers (see Cancer epigenetics). InfertilityThe gonads of FANCF mutant mice function abnormally, having compromised follicle development and spermatogenesis as has been observed in other Fanconi anemia mouse models and in Fanconi anemia patients.[26] Histological examination of the testes from FANCF-deficient mice showed that the seminiferous tubules were devoid of germ cells. At 14 weeks of age, FANCF-deficient female mice were almost or completely devoid of primordial follicles. It was concluded that FANCF-deficient mice display a rapid depletion of primordial follicles at a young age resulting in advanced ovarian aging.[26] References1. ^{{cite journal | vauthors = Joenje H, Oostra AB, Wijker M, di Summa FM, van Berkel CG, Rooimans MA, Ebell W, van Weel M, Pronk JC, Buchwald M, Arwert F | title = Evidence for at least eight Fanconi anemia genes | journal = American Journal of Human Genetics | volume = 61 | issue = 4 | pages = 940–4 | date = October 1997 | pmid = 9382107 | pmc = 1715980 | doi = 10.1086/514881 }} 2. ^{{cite web | title = Entrez Gene: FANCF Fanconi anemia, complementation group F| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2188| accessdate = }} 3. ^1 2 3 4 5 6 {{cite journal | vauthors = Léveillé F, Blom E, Medhurst AL, Bier P, Laghmani el H, Johnson M, Rooimans MA, Sobeck A, Waisfisz Q, Arwert F, Patel KJ, Hoatlin ME, Joenje H, de Winter JP | title = The Fanconi anemia gene product FANCF is a flexible adaptor protein | journal = The Journal of Biological Chemistry | volume = 279 | issue = 38 | pages = 39421–30 | date = September 2004 | pmid = 15262960 | doi = 10.1074/jbc.M407034200 }} 4. ^1 2 {{cite journal | vauthors = de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, Scheper RJ, Kruyt FA, Hoatlin ME, Joenje H | title = The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG | journal = Human Molecular Genetics | volume = 9 | issue = 18 | pages = 2665–74 | date = November 2000 | pmid = 11063725 | doi = 10.1093/hmg/9.18.2665 }} 5. ^{{cite journal | vauthors = Gordon SM, Buchwald M | title = Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems | journal = Blood | volume = 102 | issue = 1 | pages = 136–41 | date = July 2003 | pmid = 12649160 | doi = 10.1182/blood-2002-11-3517 }} 6. ^{{cite journal | vauthors = Medhurst AL, Huber PA, Waisfisz Q, de Winter JP, Mathew CG | title = Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway | journal = Human Molecular Genetics | volume = 10 | issue = 4 | pages = 423–9 | date = February 2001 | pmid = 11157805 | doi = 10.1093/hmg/10.4.423 }} 7. ^{{cite journal | vauthors = Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, Oostra AB, Yan Z, Ling C, Bishop CE, Hoatlin ME, Joenje H, Wang W | title = A novel ubiquitin ligase is deficient in Fanconi anemia | journal = Nature Genetics | volume = 35 | issue = 2 | pages = 165–70 | date = October 2003 | pmid = 12973351 | doi = 10.1038/ng1241 }} 8. ^{{cite journal | vauthors = Pace P, Johnson M, Tan WM, Mosedale G, Sng C, Hoatlin M, de Winter J, Joenje H, Gergely F, Patel KJ | title = FANCE: the link between Fanconi anaemia complex assembly and activity | journal = The EMBO Journal | volume = 21 | issue = 13 | pages = 3414–23 | date = July 2002 | pmid = 12093742 | pmc = 125396 | doi = 10.1093/emboj/cdf355 }} 9. ^{{cite journal | vauthors = Kottemann MC, Smogorzewska A | title = Fanconi anaemia and the repair of Watson and Crick DNA crosslinks | journal = Nature | volume = 493 | issue = 7432 | pages = 356–63 | date = January 2013 | pmid = 23325218 | pmc = 3700363 | doi = 10.1038/nature11863 }} 10. ^1 2 {{cite journal | vauthors = Pradhan A, Ustiyan V, Zhang Y, Kalin TV, Kalinichenko VV | title = Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage response | journal = Oncotarget | volume = 7 | issue = 2 | pages = 1912–26 | date = January 2016 | pmid = 26625197 | doi = 10.18632/oncotarget.6422 | pmc=4811506}} 11. ^{{cite journal | vauthors = Kastan MB | title = DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture | journal = Molecular Cancer Research | volume = 6 | issue = 4 | pages = 517–24 | date = April 2008 | pmid = 18403632 | doi = 10.1158/1541-7786.MCR-08-0020 }} 12. ^{{cite book | vauthors = Bernstein C, Prasad AR, Nfonsam V, Bernstein H | year = 2013 | title = Biochemistry, Genetics and Molecular Biology | chapter = DNA Damage, DNA Repair and Cancer, New Research Directions in DNA Repair | veditors = Chen C | isbn = 978-953-51-1114-6 | publisher = InTech | chapter-url = http://www.intechopen.com/books/new-research-directions-in-dna-repair/dna-damage-dna-repair-and-cancer }} 13. ^{{cite journal | vauthors = Harper JW, Elledge SJ | title = The DNA damage response: ten years after | journal = Molecular Cell | volume = 28 | issue = 5 | pages = 739–45 | date = December 2007 | pmid = 18082599 | doi = 10.1016/j.molcel.2007.11.015 }} 14. ^{{cite journal | vauthors = Dietlein F, Reinhardt HC | title = Molecular pathways: exploiting tumor-specific molecular defects in DNA repair pathways for precision cancer therapy | journal = Clinical Cancer Research | volume = 20 | issue = 23 | pages = 5882–7 | date = December 2014 | pmid = 25451105 | doi = 10.1158/1078-0432.CCR-14-1165 }} 15. ^{{cite journal | vauthors = O'Hagan HM, Mohammad HP, Baylin SB | title = Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island | journal = PLoS Genetics | volume = 4 | issue = 8 | pages = e1000155 | year = 2008 | pmid = 18704159 | pmc = 2491723 | doi = 10.1371/journal.pgen.1000155 }} 16. ^{{cite journal | vauthors = Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV | title = DNA damage, homology-directed repair, and DNA methylation | journal = PLoS Genetics | volume = 3 | issue = 7 | pages = e110 | date = July 2007 | pmid = 17616978 | pmc = 1913100 | doi = 10.1371/journal.pgen.0030110 }} 17. ^Carol Bernstein and Harris Bernstein (2015). Epigenetic Reduction of DNA Repair in Progression to Cancer, Advances in DNA Repair, Prof. Clark Chen (Ed.), {{ISBN|978-953-51-2209-8}}, InTech, Available from: http://www.intechopen.com/books/advances-in-dna-repair/epigenetic-reduction-of-dna-repair-in-progression-to-cancer 18. ^1 {{cite journal | vauthors = Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD | title = Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors | journal = Nature Medicine | volume = 9 | issue = 5 | pages = 568–74 | date = May 2003 | pmid = 12692539 | doi = 10.1038/nm852 }} 19. ^{{cite journal | vauthors = Ding JJ, Wang G, Shi WX, Zhou HH, Zhao EF | title = Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer | journal = Reproductive Sciences | volume = 23 | issue = 1 | pages = 24–30 | date = January 2016 | pmid = 26507869 | doi = 10.1177/1933719115612136 }} 20. ^{{cite journal | vauthors = Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Mansukhani M, Villella J, Meyer L, Schneider A, Gissmann L, Dürst M, Pothuri B, Murty VV | title = Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer | journal = Cancer Research | volume = 64 | issue = 9 | pages = 2994–7 | date = May 2004 | pmid = 15126331 | doi = 10.1158/0008-5472.can-04-0245}} 21. ^{{cite journal | vauthors = Wang Z, Li M, Lu S, Zhang Y, Wang H | title = Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway | journal = Cancer Biology & Therapy | volume = 5 | issue = 3 | pages = 256–60 | date = March 2006 | pmid = 16418574 | doi = 10.4161/cbt.5.3.2380}} 22. ^1 {{cite journal | vauthors = Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT | title = Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival | journal = Oncogene | volume = 23 | issue = 4 | pages = 1000–4 | date = January 2004 | pmid = 14647419 | doi = 10.1038/sj.onc.1207256 }} 23. ^{{cite journal | vauthors = Guo M, Alumkal J, Drachova T, Gao D, Marina SS, Jen J, Herman JG | title = CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer | journal = Discovery Medicine | volume = 19 | issue = 104 | pages = 151–8 | date = March 2015 | pmid = 25828518 | doi = }} 24. ^{{cite journal | vauthors = Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RS, Murty VV | title = Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors | journal = Molecular Cancer | volume = 3 | issue = | pages = 16 | date = May 2004 | pmid = 15149548 | pmc = 420487 | doi = 10.1186/1476-4598-3-16 }} 25. ^{{cite journal | vauthors = Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM | title = Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 109 | issue = 8 | pages = 3024–9 | date = February 2012 | pmid = 22315424 | pmc = 3286983 | doi = 10.1073/pnas.1200010109 }} 26. ^1 2 {{cite journal | vauthors = Bakker ST, van de Vrugt HJ, Visser JA, Delzenne-Goette E, van der Wal A, Berns MA, van de Ven M, Oostra AB, de Vries S, Kramer P, Arwert F, van der Valk M, de Winter JP, te Riele H | title = Fancf-deficient mice are prone to develop ovarian tumours | journal = The Journal of Pathology | volume = 226 | issue = 1 | pages = 28–39 | date = January 2012 | pmid = 21915857 | doi = 10.1002/path.2992 }} Further reading{{refbegin|33em}}
|
|||||||||||||||||||||
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。